In conclusion, these studies demonstrate that the TGF-β pathway plays a major role in the onset of fibrosis in mPCKS and indicate that this pathway is an interesting therapeutic target for renal fibrosis. This evidence concerns the gene TGFB1 and renal fibrosis.